Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Takeda and Capsida announce manufacturing plant investments in California 

By Brian Buntz | July 23, 2021

Takeda Capsida Biotherapeutics Thousand Oaks, CaliforniaTakeda Pharmaceuticals (NYSE:TAK) has announced that it is investing $126 million to expand a production facility in Thousand Oaks, one of the largest cities in Ventura County, California.

The money will support constructing a new 15,000-ft2 manufacturing facility and renovating an existing 14,000–ft2 plant.

The mayor of the city, Claudia Bill-de la Peña, joined Takeda officials in a groundbreaking ceremony yesterday.

In a YouTube video, Stephen Hatke, site head of Takeda, says the investment will help it grow its portfolio of treatments while bolstering production capacity for rare disease therapies.

The news coincided with a separate announcement from Capsida Biotherapeutics, Inc. to open a manufacturing plant in the same city. Capsida specializes in developing targeted gene therapies with a next-generation adeno-associated virus engineering platform.

Capsida Biotherapeutics is a relatively new entity, having launched from stealth mode after receiving $140 million in investment. The privately-held company made Thousand Oaks its headquarters.

Osaka, Japan–headquartered Takeda also has a significant history in Thousand Oaks, having set up shop there in 1996. The company currently employs approximately 550 people at the plant.

About The Author

Brian Buntz

The pharma and biotech editor of WTWH Media, Brian is a veteran journalist with more than 15 years of experience covering an array of life science topics, including clinical trials, drug discovery and development and medical devices. Before coming to WTWH, he served as content director focused on connected devices at Informa. In addition, Brian covered the medical device sector for 10 years at UBM. At Qmed, he overhauled the brand’s news coverage and helped to grow the site’s traffic volume dramatically. He had previously held managing editor roles on two of the company’s medical device technology publications. Connect with him on LinkedIn or email at bbuntz@wtwhmedia.com.

Tell Us What You Think! Cancel reply

Related Articles Read More >

Great Point Partners logo.
Great Point Partners acquires majority stake in Eutecma to fuel sustainable cold chain growth
Driving success in fast-paced high-tech pharma construction projects
This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE